| The clinical significance of uric acid and complement activation in the progression of IgA nephropathy Y Caliskan, Y Ozluk, D Celik, N Oztop, A Aksoy, AS Ucar, H Yazici, ... Kidney and Blood Pressure Research 41 (2), 148-157, 2016 | 63 | 2016 |
| Immunosuppressive treatment in C3 glomerulopathy: is it really effective? Y Caliskan, ES Torun, TO Tiryaki, A Oruc, Y Ozluk, SU Akgul, S Temurhan, ... American journal of nephrology 46 (2), 96-107, 2017 | 47 | 2017 |
| Psychological burden of COVID-19 on mild and moderate chronic spontaneous urticaria. S Beyaz, S Demir, N Oztop, P Karadag, R Coskun, B Colakoglu, ... Allergy & Asthma Proceedings 42 (4), 2021 | 18 | 2021 |
| Olanzapine as a cause of peripheric edema in an elderly man S Akın, G Bahat, F Tufan, B Saka, N Öztop, N Erten, MA Karan Aging clinical and experimental research 25, 115-117, 2013 | 16 | 2013 |
| The relation of oxidative stress biomarkers with proinflammatory cytokines in gestational diabetes S Genc, Z Kusku-Kiraz, E Dervisoglu, N Oztop, N Dinccag, F Gurdol Clin Investig 7 (2), 43-8, 2017 | 14 | 2017 |
| Diagnostic workup including CD203c‐based basophil activation test in immediate hypersensitivity due to metronidazole and ornidazole and evaluation of cross‐reactivity in between Ş Beyaz, N Akdeniz, A Yılmaz, S Demir, N Öztop, B Çolakoğlu, ... Allergy 76 (3), 842-852, 2021 | 11 | 2021 |
| The association of glycemic markers with plasma adipocytokine levels in women with gestational diabetes N Oztop, Z KÜSKÜ KİRAZ, E Dervisoglu, N Dinccag, S Genc Journal of Diabetes & Metabolism 7 (9), 2016 | 9 | 2016 |
| Positive perception of COVID-19 vaccination in HAE: No significant impact of vaccination on disease course N Oztop, S Demir, ID Toprak, D Unal, A Gelincik Allergy and Asthma Proceedings 43 (6), 546, 2022 | 7 | 2022 |
| How satisfactory is on-demand icatibant from the patients' perspective in real life? S Beyaz, S Demir, N Oztop, B Colakoglu, S Buyukozturk, A Gelincik Allergy & Asthma Proceedings 43 (2), 2022 | 6 | 2022 |
| Clinical effects of intranasal corticosteroids on nasal symptoms in subjects with chronic rhinitis during COVID-19 C Tuzer, P Karadag, O Yegit, D Eyice, N Oztop, A Can, S Demir, ... Allergy and Asthma Proceedings 43 (2), 106, 2022 | 6 | 2022 |
| Evaluation of the clinical features and laboratory data of patients with severe eosinophilic asthma classified as super-responders, partial responders, or nonresponders to … ME Cakmak, N Öztop, OO Yeğit, Ö Özdedeoğlu International Archives of Allergy and Immunology 184 (8), 736-743, 2023 | 4 | 2023 |
| Impaired endothelial function irrespective of systemic inflammation or atherosclerosis in mastocytosis N Öztop, PK Özer, S Demir, Ş Beyaz, TO Tiryaki, G Özkan, M Aydogan, ... Annals of Allergy, Asthma & Immunology 127 (1), 76-82, 2021 | 4 | 2021 |
| Common but neglected problem in chronic spontaneous urticaria: Sleep disturbance. A Can, R Coskun, DE Karabacak, OC Tuzer, OO Yegit, P Karadag, ... Allergy & Asthma Proceedings 44 (3), 2023 | 3 | 2023 |
| Predictive factors of recurrence after omalizumab cessation in the elderly with urticaria: A real-life study. N Oztop, S Demir, D Unal, S Beyaz, K Terzioglu, M Olgac, A Gelincik Allergy & Asthma Proceedings 43 (6), 2022 | 3 | 2022 |
| Impact of mental health on disease activity in mastocytosis during COVID-19 pandemic N Öztop, S Demir, Ş Beyaz, D Ünal, B Çolakoğlu, S Büyüköztürk, ... Allergology International 71 (1), 109-116, 2022 | 3 | 2022 |
| Biologics for the treatment of severe asthma: Current status report 2023 GP Çetin, SK Özdemir, ÖC Bostan, N Öztop, ZÇ Sözener, G Karakaya, ... Tuberculosis and Thorax 71 (2), 2023 | 2 | 2023 |
| Comparison of omalizumab treatment response in patients with chronic spontaneous urticaria and symptomatic dermographism: a single-center retrospective study ME Cakmak, OO Yeğit, N Öztop International Archives of Allergy and Immunology 184 (3), 236-242, 2023 | 2 | 2023 |
| Comparison of the General Characteristics of Patients with Severe Asthma Who Switched from Omalizumab to Mepolizumab versus Patients Who Responded to Omalizumab Treatment: A … MECNÖ OsmanOzanYeğit | 2 | 2023 |
| Abdominal Obesity and Metabolic Parameters in Chronic Spontaneous Urticaria. N Oztop, S Beyaz, C Orcen Medical Bulletin of Haseki/Haseki Tip Bulteni 60 (3), 2022 | 2 | 2022 |
| Evaluation of the clinical features and laboratory data of patients with severe asthma classified as super-responder or non super-responder to omalizumab treatment: a single … ME Cakmak, N Öztop, OO Yeğit, Ö Özdedeoğlu Journal of Asthma 60 (10), 1862-1868, 2023 | 1 | 2023 |
